Analgesic nephropathy diagnostic study of choice
|
Analgesic nephropathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Analgesic nephropathy diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Analgesic nephropathy diagnostic study of choice |
|
Analgesic nephropathy diagnostic study of choice in the news |
|
Risk calculators and risk factors for Analgesic nephropathy diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]
Overview
Renal biopsy is the diagnostic study of choice, however, since it is an invasive procedure, CT scan without contrast of the abdomen is usually preferred.
Diagnostic Study of Choice
Renal Biopsy
- Renal biopsy is the diagnostic study of choice.[1]
- However, renal biopsy is an invasive procedure and there is risk of complications, therefore CT scan without contrast of the abdomen is usually preferred.[1][2]
- The pathology of classic analgesic nephropathy caused by phenacetin and phenacetin-containing analgesics was caused by capillary sclerosis in the renal medulla due to toxic metabolites of phenacetin which would lead to:[3][4]
- Papillary necrosis
- Tubulointerstitial nephropathy
- Cortical atrophy
References
- ↑ 1.0 1.1 "Analgesic Nephropathy - StatPearls - NCBI Bookshelf".
- ↑ de Broe ME, Elseviers MM (1998). "Analgesic nephropathy". N. Engl. J. Med. 338 (7): 446–52. PMID 9459649. Unknown parameter
|month=ignored (help) - ↑ Mihatsch MJ, Hofer HO, Gudat F, Knüsli C, Torhorst J, Zollinger HU (1983). "Capillary sclerosis of the urinary tract and analgesic nephropathy". Clin Nephrol. 20 (6): 285–301. PMID 6641031.
- ↑ Mihatsch MJ, Khanlari B, Brunner FP (2006). "Obituary to analgesic nephropathy--an autopsy study". Nephrol Dial Transplant. 21 (11): 3139–45. doi:10.1093/ndt/gfl390. PMID 16891638.